Published in Curr Neurol Neurosci Rep on July 01, 2015
Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol (2016) 0.82
Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk. J Neurol Neurosurg Psychiatry (2016) 0.78
Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp (2016) 0.77
Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state. Eur J Neurol (2016) 0.76
Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. Neuroimage Clin (2016) 0.75
Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study. PLoS One (2017) 0.75
Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis. Acad Radiol (2017) 0.75
Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A (2002) 31.14
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73
Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A (2009) 16.93
The small world of the cerebral cortex. Neuroinformatics (2004) 6.22
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry (1970) 4.50
Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Hum Brain Mapp (2009) 4.22
p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol (2011) 3.73
Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry (1990) 2.91
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain (2012) 2.65
Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol (2011) 2.55
Correlations in low-frequency BOLD fluctuations reflect cortico-cortical connections. Neuroimage (2000) 2.52
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2007) 2.51
ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology (2009) 2.47
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry (2011) 2.45
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol (2008) 2.28
The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol (2012) 2.25
Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol (2009) 2.20
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology (2013) 2.18
Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol (2008) 2.13
Multiple sclerosis: low-frequency temporal blood oxygen level-dependent fluctuations indicate reduced functional connectivity initial results. Radiology (2002) 2.00
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain (2008) 1.94
Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage (2011) 1.88
Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res (2005) 1.84
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology (2003) 1.78
Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry (2012) 1.70
Functional motor compensation in amyotrophic lateral sclerosis. J Neurol (2005) 1.67
Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology (1997) 1.67
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain (2014) 1.67
Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis. Neurology (2012) 1.64
An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry (2010) 1.60
NERVE FIBRE DEGENERATION IN THE BRAIN IN AMYOTROPHIC LATERAL SCLEROSIS. J Neurol Neurosurg Psychiatry (1960) 1.60
Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol (2014) 1.59
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain (2011) 1.57
Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol (2009) 1.56
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. J Neurol Neurosurg Psychiatry (2011) 1.55
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology (2011) 1.49
Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers. Clin Neurophysiol (2010) 1.47
Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol Cell Neurosci (2012) 1.44
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol (2011) 1.40
Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain (1993) 1.31
Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand (1992) 1.29
Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. J Neurol Neurosurg Psychiatry (2005) 1.29
Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp (2007) 1.25
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain (2005) 1.24
Neuroimaging in amyotrophic lateral sclerosis. Biomark Med (2012) 1.23
1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology (1999) 1.20
Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol (1990) 1.20
Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS One (2011) 1.18
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler (2012) 1.18
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology (1994) 1.18
Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.18
Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One (2012) 1.17
The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol (2014) 1.15
Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One (2012) 1.15
Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry (2012) 1.14
Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One (2012) 1.13
Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43. Neuropathology (2010) 1.13
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain (2000) 1.13
Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol (1988) 1.12
Reduced Interhemispheric Functional Connectivity in the Motor Cortex during Rest in Limb-Onset Amyotrophic Lateral Sclerosis. Front Syst Neurosci (2010) 1.11
Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology (2013) 1.11
Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol (1987) 1.10
A proposed staging system for amyotrophic lateral sclerosis. Brain (2012) 1.08
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology (2014) 1.08
The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.07
Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain (2004) 1.07
Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging (2012) 1.03
Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin (2015) 1.01
Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Hum Brain Mapp (2011) 1.01
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol (2010) 1.00
Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation. J Magn Reson Imaging (2008) 1.00
Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology (2012) 1.00
Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain (2014) 0.99
Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Acta Neuropathol (2008) 0.99
Cognitive impairment in motor neuron disease. Acta Neurol Scand (1985) 0.99
Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph Lateral Scler Frontotemporal Degener (2012) 0.99
Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb Cortex (2011) 0.98
Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology (2013) 0.98
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis. Muscle Nerve (2013) 0.97
Interaction between aging and neurodegeneration in amyotrophic lateral sclerosis. Neurobiol Aging (2010) 0.96
Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph Lateral Scler (2011) 0.94
Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology (2013) 0.93
Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.93
Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis. Acad Radiol (2012) 0.92
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathol Commun (2014) 0.91
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging (2014) 0.90
Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp (2014) 0.90
Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry (2014) 0.89
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology (2011) 0.89
Alterations in regional functional coherence within the sensory-motor network in amyotrophic lateral sclerosis. Neurosci Lett (2013) 0.89
Do preprocessing algorithms and statistical models influence voxel-based morphometry (VBM) results in amyotrophic lateral sclerosis patients? A systematic comparison of popular VBM analytical methods. J Magn Reson Imaging (2013) 0.89
Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis. Hum Brain Mapp (2013) 0.89
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging (2015) 0.89
Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann Clin Transl Neurol (2014) 0.88
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain (2005) 0.88
Neuroimaging in amyotrophic lateral sclerosis. Biomark Med (2012) 1.23
Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp (2014) 0.90
Would riluzole be efficacious in the new ALS trial design? Lancet Neurol (2010) 0.75